Pfizer Inc and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion on the administration of the companies’ COVID-19 vaccine COMIRNATY® in children 5 to under 12 years of age. The European Commission (EC) will review the CHMP recommendation and is expected to make a final decision on a variation to the Conditional Marketing Authorization in the near future.
- Read more about Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European Union
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/pfizer-and-biontech-receive-positive-chmp-opinion-for-comirnaty-in-children-5-to-under-12-years-of-age-in-the-european-union
No comments:
Post a Comment